St. Joseph Hospital of Orange

Orange, California 92868

2 studies enrolling now · 17 studies all time

What they study most

Arteriovenous Fistula, Brain Cancer, Brain Tumor, Breast Cancer, Breast Cancer Risk, COVID-19, Cancer, Carcinoma, Pancreatic Ductal, GBM, Glioblastoma, Glioblastoma Multiforme, Glioma

Studies at this site

• Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST) — Recruiting now
• Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM — Completed
• Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae — Running, not enrolling
• A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma — Completed
• Study of Sargramostim in Patients With COVID-19 — Completed
• GRN-1201 With Pembrolizumab in Subjects With Metastatic PD-L1+ NSCLC — Stopped early
• Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer — Status unconfirmed
• Single Fraction Intraoperative Radiotherapy — Completed
• Intraoperative Boost Radiotherapy With Electrons (IOERT) Followed By Hypofractionated Whole-Breast Irradiation (WBRT) — Status unconfirmed
• A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer — Stopped early
• Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer — Completed
• Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study — Stopped early
• Microwave Ablation of Breast Tumors — Withdrawn before enrolling
• Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) — Stopped early
• Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA) — Completed
• Validation Study of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) — Completed
• Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 — Available (expanded access)